Tech Advance: Glutamate Pathway Inhibitors to Mitigate Neurological Disorders
Principal Investigators and Affiliations:
Spencer Knapp, Professor, Biomolecular Modeling & Design, Wright Rieman Laboratories
Jacques Y. Roberge, Director, Molecular Design and Synthesis (MD&S), Office for Research, Rutgers University Biomolecular Innovation Cores (RUBRIC)
Amount: $25,000
Sponsor: Office for Research, TechAdvance®
